Unlock instant, AI-driven research and patent intelligence for your innovation.

Microneedle coated with drug and manufacturing method for same

A manufacturing method and microneedle technology, which can be applied in the direction of drug devices, microneedles, pharmaceutical formulations, etc., can solve the problems of reducing the dip coating rate and exerting little effect, and achieve the effect of improving wrinkles and low skin permeability.

Pending Publication Date: 2021-02-09
韩国皮肤再生生物技术公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, in the case of impregnating or coating the microneedles with a drug of an active ingredient or simply mixing, there is a problem that the effect is slightly exerted because the rate of dipping coating is lowered due to the drug or the drug is not released after penetrating into the skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microneedle coated with drug and manufacturing method for same
  • Microneedle coated with drug and manufacturing method for same
  • Microneedle coated with drug and manufacturing method for same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Example 1: Manufacture of drug-coated microneedles

[0085] 1-1: Purification containing silicon dioxide (SiO 2 ) microneedle

[0086] Spongilla. fragilis Leidy needle-shaped bone pieces (289g) and sulfuric acid (80g) were put into a reaction tank and stirred for 1 hour, then water was added for additional stirring and filtered. Wash the spicules with water, and stir for 1 to 2 hours, then add NaOH and HNO respectively 3 Stirring was performed, and the pH was adjusted to 6 to 8, followed by washing with water. Finally, the spicules were washed with ethanol, filtered and dried.

[0087] 1-2: Modification containing silicon dioxide (SiO 2 ) of the microneedle surface

[0088] In order to introduce sulfhydryl (Sulfhydryl, -SH) reactive groups into purified acicular bone pieces (containing silicon dioxide (SiO 2 ) of the microneedle), carried out the hydrolysis reaction and deoxyalkylation reaction.

[0089] 1-2-1: Surface modification using hydrolysis reaction

[0...

experiment example 1

[0172] Experimental Example 1: Evaluation of Collagen Synthesis-Promoting Ability of Drugs Containing Sulfhydryl (-SH) Reactive Groups

[0173] 1-1: Selection and cultivation of cell lines

[0174] Fibroblasts (CCD-986SK) purchased from the Korean Cell Line Bank were inoculated on the bottom of the culture dish, and then penicillin (100 IU / mL), streptomycin (100 μg / mL), and 10% FBS (fetal bovine serum, Fetal bovine serum) in DMEM (Dulbecco's Modified Eagle's Medium) medium was maintained at 37° C. and cultured in an incubator containing 5% carbon dioxide.

[0175] 1-2: Cytotoxicity test method (CCK assay)

[0176] Divide fibroblasts (CCD-986SK) in 24-well (or 96-well) plate per hole 1.0×10 4 (~5.0×10 4 ), and then cultured for 24 hours under cell culture conditions. The medium was discarded, washed with PBS, and then replaced with a new DMEM medium not containing 10% FBS, and the cells were treated with predetermined concentrations of the test substances (GHK and GHK-TA) a...

experiment example 2

[0184] Experimental Example 2: Evaluation of Collagen Synthesis-Stimulating Function of Drug-Coated Microneedles

[0185] 2-1: Collagen production potential of linker (X) with Sulfhydryl (-SH) reactive group

[0186] Peptides were separated from the microneedles using 0.3 g of drug-coated microneedles (GHK-TA-MN, GHK-MPA-MN, GHK-CS-MN) manufactured in Examples 1-4 and 0.1M GSH (glutathione) 40 μl After 840 minutes, centrifuge the supernatant, then evaluate the potential of promoting intracellular collagen production in the same way as in Experimental Example 1-3, the results are as follows Figure 5 shown.

[0187] Such as Figure 5 As shown, it can be understood that there are differences in the collagen production promoting potential according to the type of linker (X) having a sulfhydryl (Sulfhydryl, -SH) reactive group. It is speculated that this difference is caused by the molecular weight of the linker with Sulfhydryl (-SH) reactive group. For reference, the molecula...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
widthaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a microneedle coated with a drug and a manufacturing method for same and, more specifically, to a microneedle coated with a drug and a manufacturing method for same, the microneedle delivering a drug by physically puncturing the stratum corneum of skin. The microneedle coated with a drug is represented by chemical formula 1 and is characterized in that the drug isdischarged by means of an oxidation-reduction reaction after the skin is penetrated. [Chemical formula 1] MN-S-S-D In chemical formula 1, MN is the microneedle containing silica (SiO2), S-S is a disulfide bond, and D is the drug. The microneedle coated with a drug according to the present invention is useful as a functional cosmetic material having whitening, wrinkle softening, anti-inflammatory functions, and the like, by effectively delivering the drug which has excellent functions but low skin permeation.

Description

technical field [0001] The present invention relates to a drug-coated microneedle and a manufacturing method thereof, and more particularly relates to a drug-coated microneedle and a manufacturing method thereof that physically perforate the stratum corneum of the skin to deliver a drug. Background technique [0002] The skin protects the human body from the external environment and is the most important tissue in terms of biochemistry and physics. It is mainly divided into epidermis, dermis and hypodermis. The stratum corneum, which is the outermost layer of the skin, has a function of regulating moisture evaporation and absorption of the skin and a barrier function against penetration of chemicals, toxic substances, and bacteria. In the stratum corneum of the skin, it takes about 14 days for the keratinocytes produced in the basal layer to reach the granular layer. In the granular layer, keratinization begins due to the action of hyaluronic acid (Keratohyalin), so that th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K47/54A61M37/00A61K8/02A61Q19/00
CPCA61K47/6923A61K47/6927A61K8/25A61K8/64A61K8/987A61Q19/08A61K2800/412A61Q19/00A61K2800/57A61K8/0245A61K47/54A61K47/545A61M37/0015A61K8/0208A61K9/0021A61M2037/0053A45D44/22A61K2800/28A61M5/32A61M2205/0238A61M2207/00B81B1/008B81B2201/055B81C1/00111B81C2201/0178
Inventor 宋炳虎郑光泽池旼宰南多瑛严惠仙金志映
Owner 韩国皮肤再生生物技术公司